DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2ACITRETIN
02 1AMINOCAPROIC ACID
03 1ANAPROX
04 1ANAPROX DS
05 1ASPIRIN AND DIPYRIDAMOLE
06 1ATENOLOL
07 1AUROVELA FE 1.5/30
08 1AUROVELA FE 1/20
09 1BOSENTAN
10 4BUPROPION HYDROCHLORIDE
11 1CAMILA
12 4CELLCEPT
13 1CLONAZEPAM
14 2CLOZAPINE
15 1DESVENLAFAXINE SUCCINATE
16 1DICLOFENAC SODIUM
17 1DILTIAZEM HYDROCHLORIDE
18 1EC-NAPROSYN
19 1ESOMEPRAZOLE MAGNESIUM
20 1FENOFIBRIC ACID
21 1GLIPIZIDE AND METFORMIN HYDROCHLORIDE
22 1GLYBURIDE AND METFORMIN HYDROCHLORIDE
23 1GUAIFENESIN
24 1GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE
25 1IBUPROFEN
26 1KELNOR
27 3LEVETIRACETAM
28 1LINEZOLID
29 1LUXZYLA
30 7METFORMIN HYDROCHLORIDE
31 1METHOCARBAMOL
32 2METOPROLOL SUCCINATE
33 8MYCOPHENOLATE MOFETIL
34 1NAPROSYN
35 2NAPROXEN
36 1NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
37 2NIACIN
38 1NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL
39 1NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE
40 1OMEPRAZOLE
41 1PENICILLIN V POTASSIUM
42 1PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE
43 1PROTONIX
44 1QUETIAPINE FUMARATE
45 1TESTOSTERONE
46 1TRACLEER
47 1TRAMADOL HYDROCHLORIDE
48 4VALACYCLOVIR HYDROCHLORIDE
49 1VENLAFAXINE HYDROCHLORIDE
01 117581
02 218164
03 120067
04 120987
05 121290
06 150722
07 150723
08 150758
09 150759
10 165379
11 165416
12 165433
13 165435
14 165477
15 174185
16 174201
17 174569
18 174949
19 175227
20 175347
21 175492
22 175978
23 176177
24 176250
25 176378
26 176785
27 176809
28 177095
29 177270
30 177478
31 177870
32 178061
33 178512
34 178783
35 178804
36 190200
37 190216
38 190564
39 190661
40 190682
41 190762
42 191123
43 191155
44 191430
45 191455
46 191625
47 1200750
48 1202095
49 1202306
50 1202742
51 1202772
52 1202774
53 1202775
54 1202897
55 1203028
56 1203059
57 1203150
58 1203636
59 1203699
60 1203755
61 1204003
62 1204206
63 1206941
64 1207505
65 1207580
66 1208999
67 1209215
68 1209324
69 1209553
70 1209921
71 1210181
72 1210497
73 1211020
74 1211629
75 1212087
76 1212882
77 1213247
01 78No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
ESOMEPRAZOLE MAGNESIUM; NAPROXEN
Drug : NAPROXEN AND ESOMEPRAZOLE MAGNESIUM
Dosage Form : TABLET, DELAYED RELEASE; ORAL
Application Number : 204206
Country : US
Patented : No
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Drug : TRAMADOL HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 78783
Country : US
Patented : No
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Drug : METFORMIN HYDROCHLORIDE
Dosage Form : TABLET; ORAL
Application Number : 90564
Country : US
Patented : No
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
MYCOPHENOLATE MOFETIL HYDROCHLORIDE
Drug : CELLCEPT
Dosage Form : INJECTABLE; INJECTION
Application Number : 50758
Country : US
Patented : No
Drug : CELLCEPT
Dosage Form : FOR SUSPENSION; ORAL
Application Number : 50759
Country : US
Patented : No
Drug : METFORMIN HYDROCHLORIDE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 202306
Country : US
Patented : No
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
